GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Cyclically Adjusted Revenue per Share

Steris (BSP:S1TE34) Cyclically Adjusted Revenue per Share : R$10.06 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Steris Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Steris's adjusted revenue per share for the three months ended in Dec. 2023 was R$3.441. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$10.06 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Steris's average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Steris was 15.80% per year. The lowest was 3.30% per year. And the median was 6.00% per year.

As of today (2024-04-30), Steris's current stock price is R$53.05. Steris's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was R$10.06. Steris's Cyclically Adjusted PS Ratio of today is 5.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Steris was 6.86. The lowest was 1.85. And the median was 3.95.


Steris Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Steris's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Cyclically Adjusted Revenue per Share Chart

Steris Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.07 8.69 9.33

Steris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.15 9.33 9.66 11.01 10.06

Competitive Comparison of Steris's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Steris's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Steris's Cyclically Adjusted PS Ratio falls into.



Steris Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Steris's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.441/129.4194*129.4194
=3.441

Current CPI (Dec. 2023) = 129.4194.

Steris Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.905 99.695 1.175
201406 0.771 100.560 0.992
201409 0.901 100.428 1.161
201412 1.039 99.070 1.357
201503 1.309 99.621 1.701
201506 1.135 100.684 1.459
201509 1.584 100.392 2.042
201512 1.545 99.792 2.004
201603 1.478 100.470 1.904
201606 1.263 101.688 1.607
201609 1.218 101.861 1.548
201612 1.268 101.863 1.611
201703 1.239 102.862 1.559
201706 1.169 103.349 1.464
201709 1.157 104.136 1.438
201712 1.272 104.011 1.583
201803 1.372 105.290 1.686
201806 1.408 106.317 1.714
201809 1.632 106.507 1.983
201812 1.582 105.998 1.932
201903 1.727 107.251 2.084
201906 1.570 108.070 1.880
201909 1.771 108.329 2.116
201912 1.856 108.420 2.215
202003 2.347 108.902 2.789
202006 2.025 108.767 2.409
202009 2.378 109.815 2.803
202012 2.419 109.897 2.849
202103 2.861 111.754 3.313
202106 2.676 114.631 3.021
202109 3.138 115.734 3.509
202112 3.390 117.630 3.730
202203 2.989 121.301 3.189
202206 2.898 125.017 3.000
202209 3.148 125.227 3.253
202212 3.184 125.222 3.291
202303 3.563 127.348 3.621
202306 3.141 128.729 3.158
202309 3.335 129.860 3.324
202312 3.441 129.419 3.441

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Steris  (BSP:S1TE34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Steris's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=53.05/10.06
=5.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Steris was 6.86. The lowest was 1.85. And the median was 3.95.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Steris Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Steris's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Steris (BSP:S1TE34) Business Description

Industry
Traded in Other Exchanges
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines